Exact Mass: 391.0783

Exact Mass Matches: 391.0783

Found 132 metabolites which its exact mass value is equals to given mass value 391.0783, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Glycoperine

(2S,3R,4R,5R,6S)-2-(4,8-dimethoxyfuro[2,3-b]quinolin-7-yl)oxy-6-methyl-tetrahydropyran-3,4,5-triol

C19H21NO8 (391.1267)

Glycoperine is an organonitrogen heterocyclic compound, an organic heterotricyclic compound and an oxacycle. Glycoperine is a natural product found in Haplophyllum acutifolium and Haplophyllum latifolium with data available.

Glucoconringiin

{[(e)-(3-hydroxy-3-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulphanyl}butylidene)amino]oxy}sulphonic acid

C11H21NO10S2 (391.0607)

Isolated from Conringia orientalis (hares ear mustard). Glucoconringiin is found in horseradish, fats and oils, and horseradish tree. Glucoconringiin is found in fats and oils. Glucoconringiin is isolated from Conringia orientalis (hares ear mustard).

Chlorohaloperidol

1-(3-(4-Chlorobenzoyl)propyl)-4-hydroxy-4-(4-chlorophenyl)piperidine hydrochloride

C21H23Cl2NO2 (391.1106)

N-4-Carboxybenzylglucamine dithiocarbamate

4-{[(2,3,4,5,6-pentahydroxyhexyl)[sulfanyl(carbonothioyl)]amino]methyl}benzoic acid

C15H21NO7S2 (391.0759)

Zidebactam

(1R,2S,5R)-7-oxo-2-(2-((R)-Piperidine-3-carbonyl)hydrazinecarbonyl)-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate

C13H21N5O7S (391.1162)

5-Chloro-2-hydroxy-7-methoxy-2H-1,4-benzoxazin-3(4H)-one beta-D-glucopyranoside

5-chloro-7-methoxy-2-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1,4-benzoxazin-3-one

C15H18ClNO9 (391.067)

5-chloro-2-hydroxy-7-methoxy-2h-1,4-benzoxazin-3(4h)-one beta-d-glucopyranoside is soluble (in water) and a very weakly acidic compound (based on its pKa). 5-chloro-2-hydroxy-7-methoxy-2h-1,4-benzoxazin-3(4h)-one beta-d-glucopyranoside can be found in corn, which makes 5-chloro-2-hydroxy-7-methoxy-2h-1,4-benzoxazin-3(4h)-one beta-d-glucopyranoside a potential biomarker for the consumption of this food product.

[1,3]Benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridine-14-aceticacid, 13,14-dihydro-13-methyl-, (+)-

C22H17NO6 (391.1056)

Glucosisaustricin

1-Ethyl-2-hydroxyethyl glucosinolate

C11H21NO10S2 (391.0607)

2-(5-chloro-2-hydroxy-7-methoxy-2H-1,4-benzoxazin-3<4H>-one)-beta-D-glucopyranoside|2-(5-chloro-2-hydroxy-7-methoxy-2H-1,4-benzoxazin-3[4H]-one)-beta-D-glucopyranoside

C15H18ClNO9 (391.067)

Asp Glu Glu

C14H21N3O10 (391.1227)

Glu Asp Glu

C14H21N3O10 (391.1227)

(S)-2-((S)-2-((S)-2-Amino-4-carboxybutanamido)-4-carboxybutanamido)succinic acid

C14H21N3O10 (391.1227)

GLYCOPERINE

NCGC00160235-01!GLYCOPERINE

C19H21NO8 (391.1267)

Glycoperine

C19H21NO8 (391.1267)

Origin: Plant; SubCategory_DNP: Alkaloids derived from anthranilic acid, Quinoline alkaloids

PharmaGSID_47330

C21H15F2N5O (391.1245)

CONFIDENCE standard compound; INTERNAL_ID 444; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8922; ORIGINAL_PRECURSOR_SCAN_NO 8921 CONFIDENCE standard compound; INTERNAL_ID 444; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8944; ORIGINAL_PRECURSOR_SCAN_NO 8942 CONFIDENCE standard compound; INTERNAL_ID 444; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8967; ORIGINAL_PRECURSOR_SCAN_NO 8965 CONFIDENCE standard compound; INTERNAL_ID 444; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8982; ORIGINAL_PRECURSOR_SCAN_NO 8980 CONFIDENCE standard compound; INTERNAL_ID 444; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8963; ORIGINAL_PRECURSOR_SCAN_NO 8961 CONFIDENCE standard compound; INTERNAL_ID 444; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8988; ORIGINAL_PRECURSOR_SCAN_NO 8987

Glu Glu Asp

C14H21N3O10 (391.1227)

Macarpine

C22H17NO6 (391.1056)

His-Asn-OH

(S)-2-(3-(2-(1H-imidazol-4-yl)ethoxy)-4-nitrobenzamido)-5-amino-5-oxopentanoic acid

C16H17N5O7 (391.1128)

Tiotropium

C19H21NO4S2 (391.0912)

3-[[4-[(2,6-dichloro-4-nitrophenyl)azo]phenyl]ethylamino]propiononitrile

C17H15Cl2N5O2 (391.0603)

Tuvatidine

C10H17N9O2S3 (391.0667)

Thiazolidine, 3-[(4-butoxyphenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)

C20H25NO3S2 (391.1276)

Eberconazole nitrate

C18H15Cl2N3O3 (391.049)

(9H-FLUOREN-9-YL)METHYL 4-CHLORO-7,8-DIHYDROPYRIDO[4,3-D]PYRIMIDINE-6(5H)-CARBOXYLATE

C22H18ClN3O2 (391.1087)

(E)-4-[3,4-bis(4-chlorophenyl)butan-2-ylamino]-4-oxobut-2-enoic acid

C20H19Cl2NO3 (391.0742)

naphthol as-tr phosphate

C18H15ClNO5P (391.0376)

TIARAMIDE HYDROCHLORIDE

C15H19Cl2N3O3S (391.0524)

D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

Rabeprazole Sulfone N-Oxide

C18H21N3O5S (391.1202)

GRI 977143

2-((3-(1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)propyl)thio)benzoic acid

C22H17NO4S (391.0878)

1,3-di-boc-2-(trifluoromethylsulfonyl)guanidine

C12H20F3N3O6S (391.1025)

(R)-N-FMOC-4-FLUOROPHENYLGLYCINE

C23H18FNO4 (391.122)

4-[(2,4-Dichloro-5-methoxyphenyl)amino]-7-fluoro-6-methoxy-3-quinolinecarbonitrile

C18H12Cl2FN3O2 (391.0291)

2H-Pyrrol-2-one, 4-acetyl-1-(4-chlorophenyl)-5-(1,4-dioxaspiro[4.5]dec-8-yl)-1,5-dihydro-3-hydroxy-

C20H22ClNO5 (391.1186)

(S)-(3-(3,4-DICHLOROPHENYL)-3-(3-HYDROXYPROPYL)PIPERIDIN-1-YL)(PHENYL)METHANONE

C21H23Cl2NO2 (391.1106)

Disperse Orange 37

C17H15Cl2N5O2 (391.0603)

Amodiaquine dihydrochloride

C20H23Cl2N3O (391.1218)

Tonabersat

C20H19ClFNO4 (391.0987)

C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent

Disperse Yellow brown Se-4br Wet Cake

C17H15Cl2N5O2 (391.0603)

N-(3-NITRO-2-PYRIDINESULFENYL)-O-T-BUTYL-L-TYROSINE

C18H21N3O5S (391.1202)

1-(3,4-Dichlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid

C19H15Cl2NO4 (391.0378)

Zidebactam

C13H21N5O7S (391.1162)

C254 - Anti-Infective Agent > C258 - Antibiotic

2-C-Methyl-6-O-methyl-5-guanylic acid

C12H18N5O8P (391.0893)

5-Hydroxy-clethodiM Sulfoxide

C17H26ClNO5S (391.122)

tert-butyl 2-methyl-2-(5-methyl-6-(oxazol-2-yl)-2,4-dioxo-1,2-dihydrothieno[2,3-d]pyrimidin-3(4H)-yl)propanoate

C18H21N3O5S (391.1202)

5-ETHYL-5 6-DIHYDRO-3 8-DINITRO-6-PHENY&

C21H17N3O5 (391.1168)

(1R,3S,4S)-3-(6-BroMo-1H-benziMidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylic acid 1,1-diMethylethyl ester

C18H22BrN3O2 (391.0895)

NBD-X, SE

C16H17N5O7 (391.1128)

N-SUCCINYL-GLY-GLY-GLY P-NITROANILIDE

C16H17N5O7 (391.1128)

(2,3,4,5,6-pentafluorophenyl) 1-(thiophen-2-ylmethyl)piperidine-4-carboxylate

C17H14F5NO2S (391.0665)

Methyl-2-bromo-3-{4-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl} propionate

C19H22BrNO3 (391.0783)

nalorphine hydrobromide

C19H22BrNO3 (391.0783)

Tavapadon

C19H16F3N3O3 (391.1144)

C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist (Rac)-Tavapadon ((Rac)-PF-06649751) is a potent and selective noncatechol dopamine D1 receptor agonist. (Rac)-Tavapadon displays potent full agonism in the GS activation assay as well as partial agonism in the β-arrestin2 recruitment assay (GS-cAMP, EC50=0.8 nM; β-arrestin2, EC50=68 nM). (Rac)-Tavapadon has antiparkinsonian activity[1]. Tavapadon (PF-06649751) is an orally active and highly selective dopamine D1/D5 receptor partial agonist. Tavapadon is effective in enabling movement and reducing disability and has the potential for Parkinson's disease[1].

n-Hydroxy-2-[4-(4-phenoxy-benzenesulfonyl)-tetrahydro-pyran-4-yl]-acetamide

C19H21NO6S (391.109)

H-1152 Dihydrochloride

C16H23Cl2N3O2S (391.0888)

Tetramethyl 7,9-dimethyl-9aH-quinolizine-1,2,3,4-tetracarboxylate

C19H21NO8 (391.1267)

N(2),N(2)-dimethylguanosine 5-monophosphate

C12H18N5O8P (391.0893)

N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]-2-[[1-(3-methylphenyl)-2-imidazolyl]thio]acetamide

C16H17N5OS3 (391.0595)

H-Glu-Glu-Asp-OH

C14H21N3O10 (391.1227)

Unii-gmy695BP6Q

C21H15F2N5O (391.1245)

TPA-023B is a high-affinity and orally active GABAA receptor α2/α3 subtype (Kis of 0.73 nM/2 nM) partial agonist and a α1 subtype (Ki of 1.8 nM) antagonist. TPA-023B has non-sedating anxiolytic-like properties[1].

5-(4-Fluorophenyl)-3-{[(4-methylphenyl)sulfonyl]amino}thiophene-2-carboxylic acid

C18H14FNO4S2 (391.0348)

4,8-dimethoxyfuro[2,3-b]quinolin-7-yl 6-deoxy-beta-D-allopyranoside

C19H21NO8 (391.1267)

2-naphthol 6-O-malonylglucoside

C19H19O9- (391.1029)

1-naphthol 6-O-malonylglucoside

C19H19O9- (391.1029)

2-(glutathion-S-yl)-2-carboxypropane

C14H21N3O8S-2 (391.1049)

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1E)-5-hydroxy-N-sulfooxypentanimidothioate

C11H21NO10S2 (391.0607)

5-Chloro-2-hydroxy-7-methoxy-2H-1,4-benzoxazin-3(4H)-one beta-D-glucopyranoside

C15H18ClNO9 (391.067)

1-S-[3-hydroxy-3-methyl-N-(sulfooxy)butanimidoyl]-1-thio-beta-D-glucopyranose

C11H21NO10S2 (391.0607)

4-Chlorobenzoic acid 2-(2-amino-3-cyano-1-pyrrolo[3,2-b]quinoxalinyl)ethyl ester

C20H14ClN5O2 (391.0836)

2-[[2-(4-chlorophenoxy)-1-oxoethyl]hydrazo]-N-(2-methoxy-5-methylphenyl)-2-oxoacetamide

C18H18ClN3O5 (391.0935)

N-(2-chloro-3-pyridinyl)-2-[[5-(3-methylanilino)-1,3,4-thiadiazol-2-yl]thio]acetamide

C16H14ClN5OS2 (391.0328)

3-[(4-Bromophenyl)methyl]-4-(4-methoxyanilino)-4-oxobutanoic acid

C18H18BrNO4 (391.0419)

2-[2-[2-(4-Chlorophenyl)-2-oxoethoxy]phenyl]isoindole-1,3-dione

C22H14ClNO4 (391.0611)

4-[5-(4-morpholinylsulfonyl)-2-thiophenyl]-3-phenyl-2H-furan-5-one

C18H17NO5S2 (391.0548)

N-[4-(4-methoxyphenyl)-2-thiazolyl]-5-methyl-2-phenyl-4-oxazolecarboxamide

C21H17N3O3S (391.0991)

N-(3,5-dichloro-2-pyridinyl)-2-[(4-methyl-2-quinolinyl)thio]propanamide

C18H15Cl2N3OS (391.0313)

N-[(2-methyl-3-nitrophenyl)-oxomethyl]-2-(4-morpholinyl)-4-thiazolecarbohydrazide

C16H17N5O5S (391.095)

5-(2,5-dichlorophenyl)-N-(2,6-dimethoxyphenyl)-2-furancarboxamide

C19H15Cl2NO4 (391.0378)

N-(5-ethyl-1,3,4-thiadiazol-2-yl)-2-[[5-[(3-methylphenoxy)methyl]-1,3,4-oxadiazol-2-yl]thio]acetamide

C16H17N5O3S2 (391.0773)

2-[(4Z)-2,5-dioxo-4-[[1-(4-phosphonophenyl)pyrrol-2-yl]methylidene]imidazolidin-1-yl]acetic acid

C16H14N3O7P (391.0569)

N-prop-2-ynyl-2,5-bis(2,2,2-triluoroethoxy)benzenesulonamide

C13H11F6NO4S (391.0313)

Asp-Glu-Glu

C14H21N3O10 (391.1227)

Glu-Asp-Glu

C14H21N3O10 (391.1227)

3-fluoro-N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1,3-thiazol-2-ylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide

C18H18FN3O4S (391.1002)

3-fluoro-N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1,3-thiazol-2-ylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide

C18H18FN3O4S (391.1002)

3-fluoro-N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1,3-thiazol-2-ylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide

C18H18FN3O4S (391.1002)

3-fluoro-N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide

C18H18FN3O4S (391.1002)

3-fluoro-N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide

C18H18FN3O4S (391.1002)

3-fluoro-N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide

C18H18FN3O4S (391.1002)

3-fluoro-N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide

C18H18FN3O4S (391.1002)

3-fluoro-N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide

C18H18FN3O4S (391.1002)

Pentetate(2-)

C14H21N3O10-2 (391.1227)

(S)-eberconazole nitrate

C18H15Cl2N3O3 (391.049)

(R)-eberconazole nitrate

C18H15Cl2N3O3 (391.049)

(2R,3S,4S,5S,6R)-2-(4,8-dimethoxyfuro[2,3-b]quinolin-7-yl)oxy-6-methyloxane-3,4,5-triol

C19H21NO8 (391.1267)

Glucoconringiin

C11H21NO10S2 (391.0607)

A hydroxy-alkylglucosinolic acid that consists of 1-thio-beta-D-glucopyranose attached to a 3-hydroxy-3-methyl-N-(sulfooxy)butanimidoyl group at the anomeric sulfur.

Glu-Glu-Asp

C14H21N3O10 (391.1227)

AZ 12216052

C19H22BrNOS (391.0605)

AZ 12216052 is a mGluR8 positive allosteric modulator, and helps mGluR8 modulate signaling inputing to retinal ganglion cells. AZ 12216052 exhibits antianxiety effect[1][2][3][4].

CAY10698

C17H17N3O4S2 (391.066)

CAY10698 (compound 1) is a potent and selective inhibitor of 12-Lipoxygenase (12-LOX) with an IC50 of 5.1 μM. CAY10698 is inactive against 5-LOX, 15-LOX-1, 15-LOX-2 and COX-1/2[1].

CTEP

C19H13ClF3N3O (391.0699)

CTEP (RO 4956371) is a novel, long-acting, orally bioavailable allosteric antagonist of mGlu5 receptor with IC50 of 2.2 nM, and shows > 1000-fold selectivity over other mGlu receptors. CTEP is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.